Edition:
United Kingdom

People: Omeros Corp (OMER.OQ)

OMER.OQ on NASDAQ Stock Exchange Global Market

20.92USD
17 Aug 2018
Change (% chg)

$0.39 (+1.90%)
Prev Close
$20.53
Open
$20.42
Day's High
$21.31
Day's Low
$20.25
Volume
124,743
Avg. Vol
216,275
52-wk High
$25.20
52-wk Low
$8.36

Demopulos, Peter 

Dr. Peter A. Demopulos, M.D., FACC, FSCAI, is Director of Omeros Corp. Dr. Demopulos is a practicing board-certified general and interventional cardiologist at Seattle Cardiology, part of the Swedish Heart & Vascular Institute. He has been a member of Seattle Cardiology since 2005, also serving as its Medical Director from 2005 to 2010. Dr. Demopulos is also a clinical assistant professor of cardiology at the University of Washington School of Medicine, a position that he has held since 1989. He participates as an investigator in clinical trials evaluating interventional cardiology devices and drug therapies at Seattle Cardiovascular Research and Swedish Cardiovascular Research. Dr. Demopulos received his M.D. from the Stanford University School of Medicine and his B.S. from Stanford University.

Basic Compensation

Total Annual Compensation, USD 35,250
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 51,050
Fiscal Year Total, USD 86,300

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gregory Demopulos

6,380,960

Michael Jacobsen

1,526,040

Marcia Kelbon

1,535,150

Thomas Cable

106,050

Peter Demopulos

86,300

Ray Aspiri

103,550
As Of  31 Dec 2016